Preoperative chemotherapy with carboplatin alone in high risk medulloblastoma

  • Rocco C. Di*
  • , A. Iannelli
  • , Marca F. La
  • , Assunta Tornesello
  • , Stefano Mastrangelo
  • , R. Riccardi
  • *Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

Few studies have been carried out regarding preoperative chemotherapy utilized in the treatment of primitive neuroectodermal tumors/medulloblastomas (PNET/MB). In this paper, the authors report 3 cases of children under three years of age, with a presumed diagnosis of PNET/MB, who were preoperatively treated with chemotherapy consisting of high doses of carboplatin alone. The treatment improved the childrens' clinical condition prior to surgery and facilitated tumor removal, resulting in partial regression of the tumor. The preoperative single-drug therapy did not affect the distological diagnosis or prevent the presence of an effective degree of tumor sensitivity to the drug. All three children are still diseasefree, after a mean follow-up period of 42 months. © 1995 Springer-Verlag.
Lingua originaleInglese
pagine (da-a)574-578
Numero di pagine5
RivistaChild's Nervous System
Volume11
Numero di pubblicazione10
DOI
Stato di pubblicazionePubblicato - 1995

All Science Journal Classification (ASJC) codes

  • Pediatria, Perinatologia e Salute del Bambino
  • Neurologia (clinica)

Keywords

  • Medulloblastoma
  • PNET
  • Preoperative chemotherapy

Fingerprint

Entra nei temi di ricerca di 'Preoperative chemotherapy with carboplatin alone in high risk medulloblastoma'. Insieme formano una fingerprint unica.

Cita questo